Evidence map›Paper›PMID 42072446›Full record

ArticleBiomedicines2026

Integrated Network Pharmacology, Molecular Docking and Experimental Validation Reveal That Quercetin Suppresses Clear Cell Renal Cell Carcinoma via MMP9-Associated Macrophage Polarization.

Jinjing Huang, Dapeng Wang, Chengyun Xu, Jianping Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jinjing HuangDepartment of Nephrology, Second Affiliated Hospital, Nanchang University, 1 Minde Road, Donghu District, Nanchang 330008, China.
Dapeng WangDepartment of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.ORCID 0000-0001-5213-4949
Chengyun XuDepartment of Nephrology, Second Affiliated Hospital, Nanchang University, 1 Minde Road, Donghu District, Nanchang 330008, China.
Jianping WuDepartment of Nephrology, Second Affiliated Hospital, Nanchang University, 1 Minde Road, Donghu District, Nanchang 330008, China.

Funding

Jiangxi Provincial Administration of Traditional Chinese Medicine's Science and Technology Project 2024B0128Jiangxi Provincial Department of Education's Science and Technology Research Project GJJ2400127
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clear cell renal cell carcinomaCuscuta chinensis Lam.immunomodulationM2 macrophagemolecular dockingnetwork pharmacology

Identifiers

PMID42072446
PMCPMC13113011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.